A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR UNTREATED PATIENTS WITH EXTENSIVE-DIASESE SMALL CELL LUNG CANCER

被引：0
|
作者：
Motoshima, Kohei [1 ]
Ogawara, Daiki [1 ]
Takemoto, Shinnosuke [1 ]
Mizoguchi, Kosuke [1 ]
Ikeda, Takaya [2 ]
Fukuda, Minoru [3 ]
Nakatomi, Katsumi [1 ]
Nagashima, Seiji [1 ]
Nakamura, Yoichi [1 ]
Kono, Shigeru [1 ]
机构：
[1] Nagasaki Univ, Dept Internal Med 2, Nagasaki, Japan
[2] Sasebo City Gen Hosp, Sasebo, Japan
[3] Japanese Red Cross Nagasaki Genbakul Hosp, Nagasaki, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu435.100
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O3-3-1
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer
    Ramalingam, S
    Belani, CP
    Day, R
    Zamboni, BA
    Jacobs, SA
    Jett, JR
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 247 - 251
  • [42] A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer
    Sohn, Joo Hyuk
    Choi, Hye Jin
    Chang, Joon
    Kim, Se Kyu
    Lee, Chang Geal
    Chung, Kyung Young
    Kim, Dae Joon
    Cho, Byoung Chul
    Shin, Sang Joon
    Moon, Yong Wha
    Kim, Joo-Hang
    LUNG CANCER, 2006, 54 (03) : 365 - 370
  • [43] The phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer
    Choi, Hye Jin
    Kim, Joo Hang
    Sohn, Joo Hyuk
    Kim, Se Kyu
    Lee, Chang Geol
    Cho, Jae Yong
    Kim, Yong Tae
    ANNALS OF ONCOLOGY, 2006, 17 : 225 - 225
  • [44] A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
    Kallab, AM
    Nalamolu, Y
    Dainer, PM
    Jillella, AP
    MEDICAL ONCOLOGY, 2005, 22 (02) : 145 - 151
  • [45] A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
    Andre Michel Kallab
    Yasolatha Nalamolu
    Paul Maclyn Dainer
    Anand Prasad Jillella
    Medical Oncology, 2005, 22 : 145 - 151
  • [46] PHASE I STUDY OF CARBOPLATIN AND AMRUBICIN WITH A BIWEEKLY SCHEDULE IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Ichiki, Masao
    Nakamura, Masayuki
    Kumano, Tomomi
    Okamoto, Masaki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S487 - S488
  • [47] PHASE II STUDY OF AMRUBICIN (AMR) COMBINED WITH CARBOPLATIN (CBDCA) FOR ELDERLY PATIENTS WITH SMALL CELL LUNG CANCER (SCLC). (NORTH JAPAN LUNG CANCER GROUP 0405)
    Nakamura, A.
    Sugawara, S.
    Harada, M.
    Usui, K.
    Suzuki, T.
    Yokouchi, H.
    Maemondo, M.
    Nukiwa, T.
    Inoue, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 117 - 118
  • [48] Phase I study of amrubicin and cisplatin in previously untreated patients with advanced non-small-cell lung cancer
    Yoshimura, N.
    Kudoh, S.
    Kimura, T.
    Mitsuoka, S.
    Yana, T.
    Hirata, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Amrubicin and carboplatin with pegfilgrastim in patients with extensive-stage small-cell lung cancer (ES-SCLC): A phase II study of the Sarah Cannon Research Institute (SCRI).
    Shipley, Dianna
    Hainsworth, John D.
    Mekhail, Tarek
    Zubkus, John D.
    Flora, Douglas B.
    Daniel, Davey B.
    Waterhouse, David Michael
    Gravenor, Donald
    Burris, Howard A.
    Greco, Frank A.
    Spigel, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer
    Fukuda, M
    Oka, M
    Soda, H
    Kinoshita, A
    Fukuda, M
    Nagashima, S
    Kuba, M
    Takatani, H
    Tsurutani, J
    Nakamura, Y
    Kasai, T
    Inoue, Y
    Soejima, Y
    Kohno, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (06) : 573 - 577
12345